NASDAQ
Icosavax, Inc. (ICVX) has a free cash flow growth of 4.51% as of Friday, May 29, 2026. This represents a 144.07% increase compared to its 12-month average of -10.23%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.